| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
343,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,897,756 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
12 |
12 |
| Total Shares Sold |
1,129,833 |
1,419,857 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$62,474,611 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
27 |
27 |
76 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schuler Jack W |
10% Owner |
– – • |
2022-08-04 |
4 |
S |
$2.46 |
$12,551 |
I/I |
(5,103) |
639,213 |
|
100% |
|
| Schuler Jack W |
10% Owner |
– – • |
2022-08-03 |
4 |
S |
$2.54 |
$6,389 |
I/I |
(2,520) |
644,316 |
|
100% |
|
| Schuler Jack W |
10% Owner |
– – • |
2022-08-02 |
4 |
S |
$2.55 |
$901 |
I/I |
(353) |
646,836 |
|
100% |
|
| Carlyle Genesis Uk Llc |
10% Owner |
– – • |
2022-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,022,602 |
|
-100% |
|
| Mackaness James H |
Chief Financial Officer |
• – – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
67,295 |
2.66 |
-20% |
|
| Mario Ernest |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
930,000 |
930,000 |
2.02 |
-20% |
|
| Mario Ernest |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
930,000 |
2,363,135 |
2.31 |
-20% |
|
| Hirano Patricia C |
See Remarks |
• – – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
20,000 |
139,104 |
2.66 |
-20% |
|
| Schuler Jack W |
10% Owner |
– – • |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
4,000,000 |
7,911,804 |
1.42 |
-20% |
|
| Anish Bhatnagar |
Chief Executive Officer |
• • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
60,000 |
430,227 |
2.73 |
-20% |
|
| Abingworth Llp |
10% Owner |
– – • |
2022-03-29 |
4 |
B |
$0.00 |
$0 |
I/I |
7,720,000 |
18,022,602 |
1.42 |
-20% |
|
| Sinclair Andrew |
Director |
– • – |
2022-03-29 |
4 |
B |
$0.00 |
$0 |
I/I |
7,720,000 |
18,022,602 |
2.02 |
-20% |
|
| Schuler Jack W |
10% Owner |
– – • |
2022-02-10 |
4 |
S |
$0.35 |
$284 |
I/I |
(800) |
3,911,804 |
|
55% |
|
| Mario Ernest |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.36 |
$20,000 |
D/D |
56,338 |
1,433,135 |
|
- |
|
| Volck Birgitte |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.36 |
$12,750 |
D/D |
35,915 |
105,678 |
|
- |
|
| Harris William G |
Director |
– • – |
2022-01-31 |
4 |
D |
$0.36 |
$4,740 |
D/D |
(13,352) |
133,518 |
|
- |
|
| Harris William G |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
42,254 |
146,870 |
|
- |
|
| Anish Bhatnagar |
Chief Executive Officer |
• – – |
2022-01-21 |
4 |
S |
$0.37 |
$14,559 |
D/D |
(39,033) |
370,227 |
|
55% |
|
| Mario Ernest |
Director |
– • – |
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
26,888 |
1,376,797 |
|
- |
|
| Volck Birgitte |
Director |
– • – |
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,141 |
69,763 |
|
- |
|
| Harris William G |
Director |
– • – |
2021-10-29 |
4 |
D |
$0.74 |
$4,740 |
D/D |
(6,373) |
104,616 |
|
- |
|
| Harris William G |
Director |
– • – |
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,167 |
110,989 |
|
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2021-09-23 |
4 |
S |
$0.88 |
$87,600 |
I/I |
(100,000) |
3,912,604 |
|
63% |
|
| Schuler Jack W |
10% Owner |
– – • |
2021-09-22 |
4 |
S |
$0.87 |
$2,270 |
I/I |
(2,599) |
4,012,604 |
|
61% |
|
| Mackaness James H |
Chief Financial Officer |
• – – |
2021-09-13 |
4 |
B |
$0.89 |
$9,981 |
D/D |
11,235 |
27,295 |
2.74 |
-66% |
|
386 Records found
|
|
Page 5 of 16 |
|
|
